peptide elongation factor 2 has been researched along with Cardiomegaly in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baksh, S; Chan, AY; Dolinsky, VW; Dyck, JR; Light, PE; Soltys, CL; Viollet, B | 1 |
| Abel, ED; Holzenberger, M; Kim, J; LeRoith, D; Litwin, SE; Sena, S; Sloan, C; Soto, J; Theobald, HA; Wayment, BE; Wende, AR | 1 |
| Chan, AY; Dyck, JR | 1 |
| Holtz, J; Jäger, D; Müller, SP; Müller-Werdan, U; Pönicke, K; Werdan, K | 1 |
1 review(s) available for peptide elongation factor 2 and Cardiomegaly
| Article | Year |
|---|---|
Activation of AMP-activated protein kinase (AMPK) inhibits protein synthesis: a potential strategy to prevent the development of cardiac hypertrophy.
Topics: AMP-Activated Protein Kinases; Animals; Cardiomegaly; Energy Metabolism; Enzyme Activation; Humans; Multienzyme Complexes; Peptide Elongation Factor 2; Phosphorylation; Protein Kinases; Protein Serine-Threonine Kinases; Signal Transduction | 2005 |
3 other study(ies) available for peptide elongation factor 2 and Cardiomegaly
| Article | Year |
|---|---|
Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Mice; Multienzyme Complexes; Myocytes, Cardiac; Peptide Elongation Factor 2; Phenylephrine; Protein Biosynthesis; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Rats; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Stilbenes; Transcription, Genetic | 2008 |
Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cardiomegaly; Cell Enlargement; Cells, Cultured; Male; Mice; Mice, Knockout; Models, Cardiovascular; Myocardial Contraction; Myocytes, Cardiac; Peptide Elongation Factor 2; Physical Exertion; Proto-Oncogene Proteins c-akt; Rats; Receptor, IGF Type 1; Receptor, Insulin; Ribonucleotides; Signal Transduction; Swimming | 2008 |
The impact of insulin-like growth factor-1 on the pattern of cardiac elongation factor-2 variants in a model of overload.
Topics: Animals; Apoptosis; Body Weight; Cardiomegaly; Disease Models, Animal; DNA Fragmentation; Enzyme Inhibitors; Genetic Variation; Heart; Hemodynamics; Hypertension; Insulin-Like Growth Factor I; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptide Elongation Factor 2; Rats; Rats, Wistar | 2002 |